These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 30610242

  • 1. Targeted intraspinal injections to assess therapies in rodent models of neurological disorders.
    Chen KS, McGinley LM, Kashlan ON, Hayes JM, Bruno ES, Chang JS, Mendelson FE, Tabbey MA, Johe K, Sakowski SA, Feldman EL.
    Nat Protoc; 2019 Feb; 14(2):331-349. PubMed ID: 30610242
    [Abstract] [Full Text] [Related]

  • 2. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.
    Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL.
    Stem Cells; 2012 Jun; 30(6):1144-51. PubMed ID: 22415942
    [Abstract] [Full Text] [Related]

  • 3. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
    Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD.
    Ann Neurol; 2014 Mar; 75(3):363-73. PubMed ID: 24510776
    [Abstract] [Full Text] [Related]

  • 4. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.
    Chen KS, Sakowski SA, Feldman EL.
    Ann Neurol; 2016 Mar; 79(3):342-53. PubMed ID: 26696091
    [Abstract] [Full Text] [Related]

  • 5. A surgical technique of spinal cord cell transplantation in amyotrophic lateral sclerosis.
    Blanquer M, Pérez-Espejo MA, Martínez-Lage JF, Iniesta F, Martinez S, Moraleda JM.
    J Neurosci Methods; 2010 Aug 30; 191(2):255-7. PubMed ID: 20600320
    [Abstract] [Full Text] [Related]

  • 6. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
    Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ.
    PLoS One; 2011 Aug 30; 6(10):e25968. PubMed ID: 21998733
    [Abstract] [Full Text] [Related]

  • 7. Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.
    Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL.
    Neurology; 2016 Jul 26; 87(4):392-400. PubMed ID: 27358335
    [Abstract] [Full Text] [Related]

  • 8. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
    Riley J, Federici T, Polak M, Kelly C, Glass J, Raore B, Taub J, Kesner V, Feldman EL, Boulis NM.
    Neurosurgery; 2012 Aug 26; 71(2):405-16; discussion 416. PubMed ID: 22565043
    [Abstract] [Full Text] [Related]

  • 9. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
    Lepore AC.
    J Vis Exp; 2011 Sep 18; (55):. PubMed ID: 21946609
    [Abstract] [Full Text] [Related]

  • 10. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Knippenberg S, Thau N, Schwabe K, Dengler R, Schambach A, Hass R, Petri S.
    Neurodegener Dis; 2012 Sep 18; 9(3):107-20. PubMed ID: 22122965
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bursch F, Rath KJ, Sarikidi A, Böselt S, Kefalakes E, Osmanovic A, Thau-Habermann N, Klöß S, Köhl U, Petri S.
    J Tissue Eng Regen Med; 2019 Apr 18; 13(4):649-663. PubMed ID: 30811816
    [Abstract] [Full Text] [Related]

  • 12. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.
    Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, Comi GP, Corti S.
    Cell Mol Life Sci; 2014 Sep 18; 71(17):3257-68. PubMed ID: 24699704
    [Abstract] [Full Text] [Related]

  • 13. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
    Srivastava AK, Gross SK, Almad AA, Bulte CA, Maragakis NJ, Bulte JWM.
    Exp Neurol; 2017 Mar 18; 289():96-102. PubMed ID: 28038988
    [Abstract] [Full Text] [Related]

  • 14. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhang C, Zhou C, Teng JJ, Zhao RL, Song YQ, Zhang C.
    Cytotherapy; 2009 Mar 18; 11(3):299-306. PubMed ID: 19333801
    [Abstract] [Full Text] [Related]

  • 15. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S, Rath KJ, Böselt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S.
    J Tissue Eng Regen Med; 2017 Mar 18; 11(3):751-764. PubMed ID: 25641599
    [Abstract] [Full Text] [Related]

  • 16. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.
    Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, Johe K, Boulis NM.
    Neurosurgery; 2014 Jan 18; 74(1):77-87. PubMed ID: 24018694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
    Hefferan MP, Galik J, Kakinohana O, Sekerkova G, Santucci C, Marsala S, Navarro R, Hruska-Plochan M, Johe K, Feldman E, Cleveland DW, Marsala M.
    PLoS One; 2012 Jan 18; 7(8):e42614. PubMed ID: 22916141
    [Abstract] [Full Text] [Related]

  • 19. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH, Lee HJ, Park IH, Seok JI, Kim BG, Joo IS, Kim SU.
    Gene Ther; 2009 Oct 18; 16(10):1234-44. PubMed ID: 19626053
    [Abstract] [Full Text] [Related]

  • 20. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
    Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, Bersano E, De Marchi F, Sarnelli MF, Querin G, Cantello R, Petruzzelli F, Maglione A, Zalfa C, Binda E, Visioli A, Trombetta D, Torres B, Bernardini L, Gaiani A, Massara M, Paolucci S, Boulis NM, Vescovi AL, ALS-NSCs Trial Study Group.
    Stem Cells Transl Med; 2019 Sep 18; 8(9):887-897. PubMed ID: 31104357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.